Brief: Erytech Pharma H1 Net Loss Widens To 35 Million Euros

Phaxiam Therapeutics SA

22/09/2020 07:04

Sept 22 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * REPORTED ON MONDAY H1 NET LOSS -35 MILLION EUR VERSUS LOSS
OF
EUR 29.3 MLN YR AGO
    * H1 TOTAL OPERATING INCOME EUR 1.8 MLN VS EUR 3.0 MLN YR
AGO
    * H1 TOTAL OPERATING LOSS EUR 35.4 MLN VS LOSS OF EUR 30.2
MLN YR
AGO
    * CASH AND CASH EQUIVALENTS OF EUR 45.4 MLN ($51.0 MLN) AT
END OF
JUNE 2020
    * CASH HORIZON EXTENDED WITH CONVERTIBLE BOND FINANCING

Source text for Eikon:  ID:nGNX1Whpl1 
Further company coverage:  ERYP.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))